ProKidney Corp.
PROKNASDAQHealthcare● Active
$1.71
$-0.09(-5.00%)
Market Cap$574994131
P/E Ratio—
52W High$7.13
52W Low$0.54
ProKidney Corp. (PROK) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PROK · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.89M | $0.08M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.89M | $0.08M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $114.12M | $127.67M | $106.71M | $82.07M | $46.26M |
| G&A Expenses | $51.78M | $56.08M | $44.81M | $70.94M | $8.86M |
| Total Operating Expenses | $165.90M | $183.75M | $151.52M | $153.01M | $55.11M |
| Operating Income | ($165.01M) | ($183.68M) | ($151.52M) | ($153.01M) | ($55.11M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $13.81M | $19.75M | $22.08M | $5.98M | $0.00M |
| Interest Expense | $0.00M | $0.01M | $0.01M | $0.21M | $0.00M |
| Income Before Tax | ($151.20M) | ($163.93M) | ($129.45M) | ($147.24M) | ($55.11M) |
| Income Tax Expense | $0.41M | ($0.60M) | $6.00M | $0.90M | $0.04M |
| Net Income | ($68.99M) | ($61.19M) | ($35.47M) | ($108.03M) | ($55.15M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.52 | $-0.62 | $-0.57 | $-1.76 | $-1.73 |
| Wtd Avg Shares | 133.94M | 97.92M | 61.71M | 61.54M | 31.89M |
| EBITDA | ($144.62M) | ($158.49M) | ($125.59M) | ($143.99M) | ($53.12M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more ProKidney Corp. data
About ProKidney Corp. (PROK) Income Statement
ProKidney Corp. (PROK) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PROK reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.07B) — a net profit margin of -7725.20%.
Frequently asked questions
PROK · 4 questionsProKidney Corp. (PROK) reported revenue of $0.00B for 2025, up 1075.0% year-over-year.
PROK revenuePROK salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08